EUCTR2012-000547-27-GB进行中（未招募）1 期
A Pilot Randomised Controlled Trial of Drug Treatment for Depression in Patients undergoing Haemodialysis - ASSertID - A Study of Sertraline In Dialysis - Version 1
East and North Hertfordshire NHS Trust0 个研究点目标入组 30 人开始时间: 2012年8月21日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •For the prevalence and screening part of the study the inclusion criteria are: 1)Patients with ESRD and on haemodialysis. They will have started dialysis at least 3 months previously and have continued to receive dialysis in the 3 months prior to the invitation to participate in this study. 2)Adults aged 18 or over. 3)Patients who speak and read English sufficiently well to complete questionnaires. For the clinical trial part of the study the inclusion criteria are: 4)Patients with a BDI II score of 16 or above. 5)Patients, who according to the nephrologist, have more than one year prognosis. 6)Patients with a diagnosis of Major Depressive Disorder according to a DSM IV interview conducted by a psychiatrist. 7)Patients who score 18 or above on the Montgomery-Åsberg Depression Rating Scale (MADRS).
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 45
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 15
排除标准
- •The exclusion criteria for the clinical trial are: 1)Patients who are currently being or have been treated for depression and/or anxiety with any antidepressants in the last 3 months. 2)Patients who are currently being or have been treated for depression and/or anxiety with a formal psychological therapy in the last 3 months. 3)Patients who are awaiting a planned living donor transplant within the period of the trial. 4)Patients who have less than a year survival prognosis according to the nephrologist. 5)Patients for whom Sertraline is contraindicated by their existing drug regimen according to the Summary of Product Characteristic. 6)Patients with hepatic impairment, whose serum level of Alanine transaminase (ALT) is 2 times the upper limits of normal or higher. 7)Patients who have hepatitis B or hepatitis C, HIV/AIDS, and/or Creutzfeldt-Jakob disease. 8)Patients who are pregnant or of childbearing potential who are not using adequate contaception. 9)Patients who are or have been involved in an intervention study in the last 3 months. 10)Patients’ with impaired coagulation judged by an International normalised ratio (INR) greater than 1.3. 11)Patients who are currently taking MAOIs or pimozide. 12)Patients who are currently taking triptans, antipsychotics, dopamine antagonists, tramadol, linezolid, and warfarin. 13)Patients at moderate to severe risk of self-harm according to the assessment of the study psychiatrist. 14)Patients who score above 4 on item 10 on the MADRS. 15)Patients who answer yes to question A3G on the Mini-International Neuropsychiatric Interview (MINI) . 16)Patients who have other known psychiatric condition, including substance misuse, psychosis, or personality disorder.
研究者
相似试验
终止
不适用
A Pilot Randomised Controlled Trial of Cognitive Behavioural Therapy for Insomnia (CBT-I) and Imagery Rehearsal Therapy (IRT) for Ex-Service Personnel with Insomnia and Nightmares in the Context of Posttraumatic Stress Disorder (PTSD) and Obstructive Sleep Apnoea (OSA).InsomniaACTRN12619000642189Gallipoli Medical Research Foundation30
进行中（未招募）
2 期
Permissive HyperthErmia Through Avoidance of Paracetamol in Known or Suspected Infection in the Intensive Care Unit (ICU) - pilot studyACTRN12611000981921Medical Research Institute of New Zealand30
已完成
不适用
Smoking Prevention in South AsiaPrevention of exposure to second hand smoke in the homeRespiratoryTuberculosis/passive smokingISRCTN83630841niversity of York (UK)150
尚未招募
不适用
A pilot randomized controlled trial investigating the feasibility, acceptability and preliminary (cost-)effectiveness and implementation of a combined lifestyle intervention for outpatients with a severe or chronic psychiatric illness (CHAPTER)Mental disorderNL-OMON53239entis (Groningen)40
已完成
不适用
Self-management and Multiple Sclerosis: The impact of a community-based exercise and education programMultiple SclerosisACTRN12613000245796Melbourne Health24